Solid Power (SLDP) investor relations material

Company overview and financials

• Founded in 2011, employs approximately 230 people, and operates two facilities in Colorado focused on pilot cell and electrolyte production.

• Market capitalization stands at $662M, with $15.3M in revenue and $435.3M in total liquidity as of March 31, 2026.

• No debt financing, with recent capital raises totaling over $220M and a DOE grant of up to $50M to expand electrolyte production.

• Commercialization strategy centers on supplying electrolyte to Tier 1 battery manufacturers and OEMs, with a presence in Korea and production lines on three continents.

• Strong intellectual property portfolio with over 20 issued US patents, about 100 pending US applications, and 110 non-US and PCT patents and applications.

Technology and product differentiation

• Specializes in sulfide-based solid electrolytes, which offer improved energy density, battery life, and safety compared to traditional lithium-ion batteries.

• Sulfide chemistry is favored by automotive OEMs and battery manufacturers for its manufacturability, ionic conductivity, and compatibility with leading ASSB cell configurations.

• Electrolyte innovation center enables rapid feedback and improvements, supporting partners' cell programs and accelerating development at lower costs.

• Wet process method for electrolyte production reduces capital and energy requirements, enhances scalability, and improves yield compared to dry processing.

• Product line includes multiple generations of LiPSCI argyrodite powders, with increasing ionic conductivity and consistent particle metrics.

Commercialization and manufacturing scale-up

• Two pilot electrolyte manufacturing lines currently have a capacity of 30 metric tons per year, with plans to expand to 75 metric tons by end of 2026.

• Exploring commercial-scale production partnerships in Korea and installing a continuous manufacturing pilot line.

• Capital efficiencies are expected from focusing on electrolyte production rather than cell manufacturing.

• Li2S precursor supply is projected to meet demand prior to mass commercialization, with alternative production routes under development.